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Abbreviations
T1DM – Type 1 Diabetes Mellitus
T2DM – Type 2 Diabetes Mellitus
AAP – American Academy
of Pediatrics
HgbA1C – Hemoglobin A1C
What’s Known on This Subject:
Type 1 diabetes is increasing in
children both nationally and in West
Virginia. Vitamin D supplementation
early in life has been shown
to be protective against the
development of type 1 diabetes.
What This Study Adds:
Our systematic literature review
gathers an overwhelming amount of
evidence regarding the relationship
of Type 1 diabetes and vitamin
D supplementation. By doing so
we are able to encourage further
study to clarify the effective
dosage of supplementation
and to emphasize the potential
benefits of providing currently
recommended supplementation.
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Abstract
Vitamin D deficiency is associated
with multiple childhood diseases
including type 1 diabetes mellitus
(T1DM). T1DM in children is
becoming more prevalent, with a 23%
increase nationally from 2001 to 2009.
Similarly, West Virginia has had an
8.1% increase in children with type 1
Diabetes from 2008/2009 to 2010/2011.
This article highlights the association
between vitamin D and type 1 diabetes
and discusses vitamin D’s potential
role in the reduction and management
of T1DM in children.

Introduction
The incidence of type 1 diabetes
mellitus (T1DM) in children rose
23% nationally between 2001 and
2009.1 More recently, West Virginia’s
T1DM in children dramatically rose
8.1% from 2008/2009 to 2010/2011.2
T1DM is an autoimmune disease
that results in the destruction of
pancreatic beta cells, resulting
in insulin dependence. Multiple
genes and environmental
factors have been implicated in
triggering the onset of T1DM.3
A large case control study by the
EURODIAB group suggests that
regular vitamin D supplementation
in childhood can help prevent the
development of T1DM characterized
by a progressive autoimmune
destruction of pancreatic beta
cells.4 Exact mechanisms that
confer this protection are not
defined but studies suggest that
the biologically active form of
vitamin D – 1, 25 hydroxyvitamin
D3 – is an immunomodulator.5,6
Vitamin D supplementation
reduces lymphocyte proliferation
and promotes a shift of type 1
T helper to type 2 T helper cell
immune response.5,6 Therefore,
a deficiency of vitamin D may
predispose the beta cells to
autoimmune destruction.7-9
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Vitamin D deficiency is common
among chronic and newly diagnosed
type 1 diabetics.10 Since vitamin
D levels are affected by sun
exposure, the fact that multiple
studies showed that T1DM is more
commonly diagnosed in winter
would support an association.10,11
Studies have also shown a positive
correlation between latitude and
T1DM diagnosis.11,12 For West
Virginia, our location increases our
risk of vitamin D deficiency because
little if any cutaneous production
of vitamin D occurs from midOctober to mid-March.12,13 It is worth
noting that living in a temperate
climate does not automatically
confer potential protection against
T1DM because sufficient vitamin
D levels are needed for protective
benefits.14,15 To account for these
geographic differences, multiple
groups have recommended vitamin
D supplementation. The American
Academy of Pediatrics (AAP) in 2008
increased their recommendation for
vitamin D supplementation to 400
IU per day for all children beginning
in infancy.16 Compliance with these
recommendations is concerning with
less than half of infants and children
receiving this amount of vitamin D.17
This article further explores the
literature as it pertains to three
aspects of vitamin D and type 1
diabetes. First it considers the
finding of vitamin D deficiency at
the time of diagnosis of type 1
diabetes. Second, potential effects
of vitamin D in the prevention of
type 1 diabetes are considered.
Finally, the possible importance
of vitamin D supplementation in
already diagnosed individuals
with T1DM is examined.

Methods
The National Library of Medicine
Medline database was systematically
searched through May 31, 2013
for vitamin D and type 1 diabetes
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in children. Search terms included
“type 1 diabetes”, “vitamin D
deficiency”, and “childhood vitamin
D supplementation.” This search
resulted in 71 articles which were
then screened by all four authors
in order to eliminate those dealing
with animal studies, adults, type
2 diabetes, genomic analysis and
other diseases such as asthma and
atopic dermatitis. This resulted in
a total of 17 articles remaining that
were specific to vitamin D and type
1 diabetes in children (ages 0-20).
All 17 of these articles are listed in
Table 1 and include meta-analyses,
other systematic literature reviews,
birth cohort studies, case control
studies, randomized control studies
and observational studies. Table 1
details each article in regard to the
author, year, design, and findings.

Results
An association between vitamin
D deficiency and the diagnosis of
T1DM was apparent in multiple
studies. A German study of 49 newly

diagnosed type 1 diabetics within
48 hours of initial hospitalization
showed that there was a significant
decrease of 1,25 hydroxyvitamin
D3 or 1,25(OH)2D3 in the subjects
compared to controls without
disease (39±2 vs. 55±4 pg/ml).18 A
study of 170 young Qatari children
and 170 case controls demonstrated
an association between lower
levels of Vitamin D and T1DM.
There was a significant difference
found in the mean level of vitamin
D (p= 0.0009).15 A Swedish study
investigated 459 young adults with
newly diagnosed T1DM at the time
of diagnosis, as well as 138 of those
subjects 8 years later. The levels of
plasma 25-hydroxyvitamin D was
significantly lower in type 1 diabetics
than in controls at diagnosis (82.5
vs. 96.7 nmol/l; p<0.0001) and
eight years later plasma levels had
continued to decrease in children
with T1DM.19 Interestingly, there
was no relationship between the
documented vitamin D levels and
HgA1C suggesting that vitamin D
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has no influence on blood glucose
control. On a similar note, another
study aimed to assess whether the
degree of diabetic control has an
association with Vitamin D. Patients
with established T1DM were
categorized as either controlled or
poorly controlled diabetics and the
level of Vitamin D was not found to
be significantly different. 20 A study
in Italy revealed lower levels of
both 1,25 – (OH)2D3 and 25-(OH)
D3 in 88 newly diagnosed type 1
diabetics compared to controls living
in the same geographical areas.6
Similarly a Northern Indian study
evaluated the Vitamin D levels of
50 recently diagnosed children.14
The mean levels of vitamin D were
significantly lower in these cases
(20.02±10.63 ng/ml, 50.05±26.57
mmol/l) compared with the 50
control children. Of these children
with significantly low Vitamin D
levels, 33 (66%) had presented in
significant ketoacidosis. Contrary
to the multiple studies showing
an inverse association between
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Table 1.
REFERENCE

AUTHOR

YEAR

4

EURODIAB Study
Group

1999

DESIGN
Case control
study

FINDINGS
• 7 centers in Europe studied 820 T1DM patients aged birth
to 14 and 2335 controls
• Found Vitamin D supplementation in infancy was
associated with a decreased risk of developing T1DM.
Combined odds ratio of children was 0.67

6

Pozzilli, P. et al.

2005

Surveillance
study

• 88 consecutive newly diagnosed T1DM and in 57 healthy
age and sex matched subjects
• Mean levels of both 25OHD3 and 1,25OH2D3 were
significantly lower in patients compared to controls (p<0.01
and p<0.03, respectively)

34

10

Janner, M. et al.

2010

Prospective
cross sectional
study

• 129 diabetic youth
• The vitamin D levels of diabetics showed marked seasonal
fluctuations, but no relationship to diabetic control.

11

Alemzadeh, R.
et al.

2008

Retrospective
Case-cohort

• 127 children and adolescents (ages 6.0-17.9 years) who
met the criteria for obesity (BMI >95th percentile)
• Although mean serum glucose levels and HbA1c were
similar among groups, serum insulin levels were slightly
highers in the hypovitaminosis D group than in the vitamin
D-sufficient group, but did not reach statisitical significance

14

Borkar, V.V. et al.

2010

Cross
sectional case
control study

• 50 children aged 6-12 years within one week of diagnosis of
T1DM and in 50 healthy children
• Mean levels of Vitamin D were significantly lower in patients
compared to their controls [20.02 ± 10.63 ng/ml vs. 26.16 ±
12.28 ng/ml, p = 0.009]

15

Bener, A. et al.

2009

Matched casecontrol study

• Studied 170 diabetics and 170 controls of male and female
Qatari children (less than 16 years old)
• Vitamin D deficiency was considerably higher in T1DM
children (90.6%) compared to controls (85.3%)
• There was a significant difference found in the mean value
of Vitamin D between T1DM and non-diabetic children
(p=0.009).
• Vitamin D supplementation with breast milk was very poor
in diabetic children (47.7%).
• Family history of Vit. D deficiency was higher in diabetics
compared to non-diabetics (p<0.012).

18

Baumgartl, H.J.
et al.

1991

19

Littorin, B. et al.

2006

• 49 recently diagnosed diabetics were compared with 42
healthy controls
• A marked decrease of 1,25OH2D3 was found at the onset
of diagnosis compared to normal controls (p <0.01).
• Grouping of patients according to season demonstrated
that the decrease of 1,25OH2D3 was present primarily
during the summer months and likely due to a loss of
seasonal rhythm of this hormone observed in healthy
controls (p<0.001)
Cross
sectional study

• Plasma 25OHD3 levels were measured in 459 patients at
the time of diagnosis and in 138 of those patients 8 years
later
• At diagnosis, plasma 25OHD3 were signficantly lower in
patients with T1DM than in controls (p<0.0001).
• 8 years later, plasma 25OHD3 had decreased in patients
(p=0.04).
• Plasma levels of 25OHD3 were significantly lower in
diabetic males than females at diagnosis and followup
(p<0.0001 and p=0.048, respectively)
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REFERENCE

AUTHOR

YEAR

DESIGN

FINDINGS

20

Simmons, J. et al.

2011

Cross
sectional study

• 57 adolescents with T1DM who had HbA1c > 9%
(unfavorable control) and <9% (favorable control).
• Study revealed no difference between HbA1c groups in
Vitamin D status.
• The prevalence of vitamin D deficiency was similar to that
of the general population.

21

Mutlu, A. et al.

2011

Cross
sectional study

• Evaluated 120 children and adolescents (aged 3-20)
levels of 25OHD, Parathyroid hormone, and Alkaline
phosphatase, as well as A1c and daily insulin requirements.
• Controls were more likely to be Vitamin D deficient,
compared to only 21.7% T1DM patients.
• There were no correlations between insulin requirements
and 25OHD level.

22

Zipitis, C.S. and
A.K. Akobeng

2008

Meta-analysis

• Total number of participants was 1429 cases and 5026
controls
Data from the case control studies showed risk of T1DM was
significantly reduced in infants who were supplemented with
Vitamin D compared to those who were not (pooled odds
ratio 0.71, 95% CI 0.60 to 0.84)

23

Hypponen, E. et
al.

2001

Birth cohort
study

• 10,821 children were included in the analysis and followed
up at one year
Vitamin D supplementation was associated with a decreased
frequency of T1DM.
• Regular vs no supplementation 0.12 (95% CI 0.03-0.51)
and irregular vs no supplementation 0.16 (95% CI 0.040.74)
• Children who regularly took the supplementation had a RR
of 0.22 (0.05-0.89) compared to those that received less
than the recommended amount.

24

Brekke, H.K. and
J. Ludvigsson

2007

Birth cohort
study

• 16,070 infants were included at birth, and 11,081 and 8805
at 1 and 2.5 years, respectively
• Use of vitamin D associated supplements during
pregnancy was associated with a reduced diabetes related
autoimmunity at 1 yr (adjusted odds ratio 0.707, p=0.028),
but not at 2.5 years

25

Greer, R.M. et al.

2007

Retrospective

• Children and adolescents with diabetes were more than 3x
as likely to have vitamin D deficiency as those in the control
group

26

Svoren, B.M. et
al.

2009

Cross
sectional study

• 25OHD3 was measured in 128 youth with T1DM
• The majority of youth with T1DM had inadequate levels:
insufficiency (61%) or deficiency (15%), with only 24%
being sufficient.
• Participants with Vitamin D deficiency were significantly
older (p<0.001) and had a longer diabetes disease duration
(p<0.01) and had lower HbA1c (p=0.05)

27

Frazer, T.E. et al.

1981

28

Kaur, H. et al.

2011

• 45 white insulin dependent age 7-18yr diabetics
• Circulating 24,25OH2D3 was significantly elevated and
1,25OH2D3 was significantly decreased.
• The increase in 24,25OH2D3 was seen in diabetics with the
most severe bone loss and maximally increased during the
first 5 years of disease
Cross
sectional study
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• Vitamin D levels were measured in 517 patients age 8-20
• Retinopathy was more prevalent in patients with vitamin D
deficiency (18 vs. 9%, p=0.02).
• In logistic regression, retinopathy was associated with
vitamin D deficiency (odds ratio 2.12 CI 1.03-4.33),
diabetes duration (1.13, 1.05-1.23), and HbA1c (1.24,
1.02-1.50).

January/February 2015 | Vol. 111

35

Review Article |

vitamin D levels and T1DM, one
study showed that vitamin D
deficiency was higher in healthy
controls as compared to diabetics.21
The preponderance of evidence
demonstrates that vitamin D
deficiency is apparent at the time
of diagnosis of T1DM, as well
as throughout the course of the
disease. This has led to additional
studies attempting to determine
whether supplementation could
potentially prevent TIDM. A
systematic review and meta-analysis
sought to determine whether or
not the development of T1DM
was associated with a lack of
vitamin D supplementation.22 This
analysis showed that the risk of
T1DM was significantly reduced in
infants supplemented with vitamin
D compared to infants who were
not (pooled odds ratio 0.71, 95%
CI 0.60 to 0.84). The study also
showed some evidence of a dose
response, but further research is
needed to confirm this finding. A
birth cohort study in Finland was
done to determine whether dietary
vitamin D supplementation was
associated with a reduced risk of
T1DM.23 Serum levels were analyzed
at birth and again at one year in
10,821 children. Supplementation
was associated with a significantly
decreased occurrence of
T1DM. Children who took any
supplementation, regardless of dose,
had a lower rate of development of
T1DM than children who receive
no supplementation. Regular
supplementation (400IU) was
associated with an 80% reduction
of the risk for development of
T1DM.17 The EURODIAB case
control study compared 800 T1DM
children to 2000 healthy controls
and also found that supplementation
of vitamin D in infancy decreased
the risk of T1DM.4 The effect was
most obvious in patients with a later
onset of disease. Notably those
who received supplementation for
one year or less showed a similar
reduction in risk as compared to
those with supplementation for a
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year or longer. Lastly, a study of
vitamin D supplementation during
infancy with follow up at 1 and 2.5
years was performed to determine
the effects of supplementation on
development of T1DM. This study
also looked at whether consumption
of vitamin D during pregnancy
had an effect on development of
disease in the child.23 The use of a
vitamin D containing supplement
during pregnancy was associated
with a reduction of diabetes related
autoimmunity at 1 year of age, but
no difference at 2.5 years of age.
Vitamin D deficiency remains
present throughout the course of
the disease and in some cases will
actually worsen as the duration
of illness lengthens. This leads
one to consider whether vitamin
D supplementation is important
in the management of those
already diagnosed. A matched
case control study evaluated the
extent of vitamin D deficiency in
populations of children already
diagnosed with T1DM.15 This study
showed that vitamin D deficiency
was considerably higher in T1DM
children (90.6%) compared to nondiabetic children (85.6%). A similar
Australian study demonstrated
that children and adolescents with
T1DM were three times more likely
to have a deficiency of vitamin D as
compared to the control group.25 A
cross sectional study of adolescents
with T1DM determined that
participants with a longer duration
since diagnosis had more severe
vitamin D deficiency.26 In patients
with a preexisting diagnosis of
T1DM, circulating levels of inactive
24, 25-(OH) 2D concentrations were
significantly elevated; whereas active
1, 25-(OH) 2D3 was significantly
decreased. The increase in levels of
24, 25-(OH) 2D was more severe in
diabetics with significant bone loss. It
was also maximally increased during
the first 5 years of clinical disease.27
Since vitamin D may confer
protection through anti-inflammatory
effects, retinopathy is a possible
complication in diabetics, especially
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with insufficient vitamin D levels.28
In a cross sectional study of 157
adolescents aged 8-20 attending
diabetes complications assessment
services, retinopathy was more
common in young adults with T1DM
than controls. These results were
independent of duration of illness
or hemoglobin AIC (HgbA1C).

Discussion
Although there is no vitamin D
level that has been established
as either protective or predictive
for the development of T1DM,
multiple studies have demonstrated
the importance of vitamin D
supplementation early in infancy and
childhood and its preventative effects
on autoimmune disease. Nearly
all of the studies in this review
mention that vitamin D acts through
immunomodulation and can be
preventative in the development of
Type 1 diabetes. Some studies have
indicated a possible dose dependent
response when supplemented
in infancy with a greater effect of
supplementation from 7-12 months
of age versus birth to 6 months.22
Another direction of research
focuses on whether some individuals
are genetically predisposed to a
vitamin D deficiency, therefore at
greater risk of T1DM. Vitamin D
gene receptor polymorphisms have
been linked to T1DM that may
interfere with absorption of Vitamin
D in the gut.6 Normally, vitamin D
leads to a reduction of lymphocyte
proliferation and cytokine
production in the gut mucosa.
Early in infancy, vitamin D helps in
the development and maturation
of the gut mucosa and limits the
exposure to large molecular weight
proteins with potentially antigenic
properties, such as cow’s milk.
Thus susceptible individuals may
not be able to adequately absorb
vitamin D in their diets due to the
genetic predisposition leading to
T1DM. However, further research
is needed to determine the impact
of this possible genetic link.
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Conclusion
In conclusion, an overwhelming
amount of evidence has shown
that vitamin D deficiency may be
implicated in the development
of T1DM in the pediatric
population. Furthermore, vitamin
D supplementation early in life
has shown to be protective
against the development of the
disease. However, further research
is needed to determine the
significance of vitamin D levels and
supplementation on development
and course of T1DM. Evidence of
effective dosage of supplementation
as well as duration is needed to
develop a standard of care for the
prevention of this disease. Although
the research is inconclusive, it is
clear that vitamin D supplementation
is recommended and even a modest
dose may be beneficial. In light
of the fact that Type 1 diabetes is
increasing in our pediatric population
in West Virginia, it seems we should
at least ensure that we are giving
the dosage of vitamin D currently
recommended by the AAP.
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Invitation
for
Submissions
to a
Vignette
Series

Compassion
in
Medicine
The West Virginia Medical
Journal (WVMJ) is soliciting
vignettes from West Virginia
physicians, who have practiced
in the state for at least 10
years. Vignettes should
highlight experiences in which
their patient care inspired
or educated the author in a
meaningful way.
Submissions are limited to 700
words. Please accompany
your submission with a cover
letter, including your name,
address, email address, title
and employment affiliation
and years in practice.
Submissions are open to all
West Virginia physicians.
Vignettes will be published
periodically throughout the
year, without specific notice of
a scheduled publication date.
Please be sure the submission
contains no identifiable
patient information. Only one
submission per author.
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